Literature DB >> 3071496

Alternative therapies for high-risk elderly rheumatic patients.

M Lequesne1.   

Abstract

The main high-risk conditions among elderly rheumatic patients are peptic ulcer, renal or hepatic insufficiencies, and bleeding problems (either spontaneous or iatrogenic). Because the incidence of these conditions is significant, elderly patients should be monitored for them regularly. Although nonsteroidal antiinflammatory drugs (NSAIDs) generally are avoided, these agents can be used in selected patients. High-risk elderly rheumatoid arthritis patients can be given prednisone and a carefully chosen disease-modifying antirheumatic drug. Although analgesics can be used instead of NSAIDs, their efficacy is poor. Local therapy, i.e. intraarticular injections, and even surgery are good alternative resources. In Europe, patients with osteoarthritis are often treated with NSAIDs. High-risk elderly patients may receive sufficient relief with analgesics. If relief is not adequate, hip or knee total prosthesis procedures must be performed earlier than would normally be done.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3071496     DOI: 10.1159/000212985

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  4 in total

1.  Intra-articular steroid hip injection for osteoarthritis: a survey of orthopedic surgeons in Ontario.

Authors:  John Kaspar; Sam Kaspar; Cinzia Orme; Justin de V de Beer
Journal:  Can J Surg       Date:  2005-12       Impact factor: 2.089

Review 2.  The problems and pitfalls of NSAID therapy in the elderly (Part II).

Authors:  A G Johnson; R O Day
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

Review 3.  Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance.

Authors:  A G Johnson; P Seideman; R O Day
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

Review 4.  Rheumatoid arthritis in the aged. Incidence and optimal management.

Authors:  G Nesher; T L Moore
Journal:  Drugs Aging       Date:  1993 Nov-Dec       Impact factor: 3.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.